In a recent report, overexpression of BRCA1 and other genes (p53, p21, GST, MDR1 and TOPOIIα) have been associated with acquired resistance to doxorubicin in breast cancer cell lines [32]. This evidence concerns the gene BRCA1 and breast cancer.